VBI Vaccines Stock Price, News & Analysis (TSE:VBV)

C$4.70 +0.08 (+1.73 %)
(As of 02/16/2018 04:00 PM ET)
Previous CloseC$4.70
Today's RangeC$4.62 - C$4.70
52-Week RangeC$3.85 - C$8.94
Volume2,000 shs
Average Volume3,345 shs
Market CapitalizationC$239.53 million
P/E Ratio-5.16
Dividend YieldN/A

About VBI Vaccines (TSE:VBV)

VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process. The company also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants. In addition, it is developing CMV vaccine program, which is in Phase I clinical trials for the prevention of human cytomegalovirus infection; and for glioblastoma multiforme, which is in preclinical testing stage. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Receive VBV News and Ratings via Email

Sign-up to receive the latest news and ratings for VBV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-5.16483516483517
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSC($0.91)
Net IncomeN/A
Net Margins-5,078.76%
Return on Equity-59.42%
Return on Assets-43.57%


Outstanding Shares63,805,000

VBI Vaccines (TSE:VBV) Frequently Asked Questions

What is VBI Vaccines' stock symbol?

VBI Vaccines trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VBV."

When will VBI Vaccines make its next earnings announcement?

VBI Vaccines is scheduled to release their next quarterly earnings announcement on Friday, March, 23rd 2018. View Earnings Estimates for VBI Vaccines.

Who are some of VBI Vaccines' key competitors?

Who are VBI Vaccines' key executives?

VBI Vaccines' management team includes the folowing people:

  • Steven D. Rubin, Chairman of the Board
  • Curtis A. Lockshin Ph.D., Chief Executive Officer, Director (Age 56)
  • Athena Kartsaklis, Principal Financial and Accounting Officer, Senior Vice President - Finance, Chief Compliance Officer, Corporate Controller (Age 52)
  • Shayla Forster, Corporate Secretary
  • Dmitry Genkin, Director
  • Kate Inman, Director
  • Tomer Kariv, Director (Age 57)
  • Adam Logal, Director
  • David S. Rector, Additional Independent Director (Age 70)

How do I buy VBI Vaccines stock?

Shares of VBI Vaccines and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is VBI Vaccines' stock price today?

One share of VBI Vaccines stock can currently be purchased for approximately C$4.70.

How big of a company is VBI Vaccines?

VBI Vaccines has a market capitalization of C$239.53 million.

How can I contact VBI Vaccines?

VBI Vaccines' mailing address is 222 3rd St Ste 2241, CAMBRIDGE, MA 02142-1259, United States. The company can be reached via phone at +1-617-8303031.

MarketBeat Community Rating for VBI Vaccines (VBV)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  28
MarketBeat's community ratings are surveys of what our community members think about VBI Vaccines and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

VBI Vaccines (TSE:VBV) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


VBI Vaccines (TSE:VBV) Earnings History and Estimates Chart

Earnings by Quarter for VBI Vaccines (TSE:VBV)

VBI Vaccines (TSE VBV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q3 2017C($0.29)C($0.30)ViewN/AView Earnings Details
7/31/2017Q2 2017C($0.28)C($0.30)ViewN/AView Earnings Details
3/24/2017Q4 2016C($0.24)ViewN/AView Earnings Details
8/15/2016Q2 2016C($0.30)ViewN/AView Earnings Details
11/16/2015Q3 2015C($0.40)ViewN/AView Earnings Details
8/14/2015Q2 2015C($0.40)ViewN/AView Earnings Details
2/6/2015Q4 2014C($0.40)ViewN/AView Earnings Details
8/12/2014Q2 2014C($0.40)ViewN/AView Earnings Details
6/25/2014Q1 2014C($1.20)ViewN/AView Earnings Details
2/13/2014Q4 2013C($0.40)ViewN/AView Earnings Details
11/13/2013Q3 2013C($0.40)ViewN/AView Earnings Details
2/12/2013Q4 2012C($0.40)ViewN/AView Earnings Details
11/13/2012Q3 2012C($0.68)ViewN/AView Earnings Details
8/15/2012Q2 2012C($0.36)ViewN/AView Earnings Details
6/29/2012Q1 2012C($0.80)ViewN/AView Earnings Details
3/26/2012Q1 2010C($0.40)ViewN/AView Earnings Details
2/29/2012Q4 2011C($0.56)ViewN/AView Earnings Details
11/30/2011Q3 2011C($0.68)ViewN/AView Earnings Details
9/28/2011Q2 2011C($0.88)ViewN/AView Earnings Details
7/28/2011Q1 2011C($5.48)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


VBI Vaccines (TSE:VBV) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for VBI Vaccines (TSE:VBV)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

VBI Vaccines (TSE VBV) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for VBI Vaccines (TSE:VBV)

VBI Vaccines (TSE VBV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017Jeffrey Royston BaxterDirectorBuy4,609C$3.88C$17,882.92
11/28/2017Jeffrey Royston BaxterDirectorBuy15,000C$4.75C$71,250.00
8/21/2017Francisco Diaz-MitomaInsiderBuy3,000C$3.17C$9,510.00
8/21/2017Jeffrey Royston BaxterDirectorBuy10,000C$3.22C$32,200.00
(Data available from 1/1/2013 forward)


VBI Vaccines (TSE VBV) News Headlines


SEC Filings

VBI Vaccines (TSE:VBV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


VBI Vaccines (TSE VBV) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.